[1] ZHAO Y, ATUN R, OLDENBURG B, et al.Physical multimorbidity, health service use, and catastrophic health expenditure bysocioeconomic groups in China: an analysis of population-based panel data[J]. Lancet Glob Health, 2020, 8(6): e840-e849. [2] National Key Research and Development Project research Group (2018YFC2002400). Expert consensus on the safety management of multiple medications for elderly comorbidities patients[J]. Chinese Journal of Health Care and Medicine(中华保健医学杂志), 2021, 23(5): 548-554. [3] JIANG J, ZHANG YF, WANG JL, et al.Investigation and analysis of the complexity and suitability of drug treatment plans for elderly hospitalized patients[J]. Chinese Journal of Clinical Pharmacy(中国临床药学杂志), 2021, 30(3): 196-200. [4] HANSON K, MATTES RG, CAUTHON KAB.Drug eruption from atorvastatin: with initial misdiagnosis of tinea cruris[J]. Sr Care Pharm, 2023, 38(2): 63-69. [5] GRESSIER L, PRUVOST-BALLAND C, DUBERTRET L, et al.Syndrome d’hypersensibilité médicamenteuse induit par l’atorvastatine [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)][J]. Ann Dermatol Venereol, 2009, 136(1): 50-53. [6] CAO X, LI YJ, SONG YQ, et al.Allergic reactions Induced by Statins[J]. Evaluation and analysis of drug use in hospitals of China, 2022, 22(1): 125-128. [7] LI YY. 5 Cases of adverse reactions caused by injection of urinary kallidinogenase[J]. Chinese Journal of Pharmacovigilance (中国药物警戒), 2008, 5(5): 317, 319. [8] XU J, WANG A, MENG X, et al.Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase iii, randomized, double-blind, comparative trial[J]. Stroke, 2021, 52(3): 772-780. [9] WANG W, CEHN XL, WU SF.Analysis of 4760 ADR reports of aspirin enteric-coated tablets[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2019, 16(6): 354-356. [10] Chinese Medical Association, Journal of the Chinese Medical Association, Dermatology and Venereology Branch of the Chinese Medical Association, General Practitioner Branch of the Chinese Medical Association, Editorial Committee of the Chinese Journal of General Practitioners of the Chinese Medical Association, and Expert Group for Writing Grassroots Diagnosis and Treatment Guidelines for Dermatology and Venereology. Guidelines for grassroots diagnosis and treatment of drug rash[J]. Chinese Journal of General Practitioners(中华全科医师杂志), 2022, 21(9): 804-813. [11] Prevention of Food and Drug Allergy Group of the Allergic Disease Prevention and Control Professional Committee of the Chinese Association of Preventive Medicine. Expert consensus on Drug Stimulation Trials[J]. Chinese Journal of Preventive Medicine(中华预防医学杂志), 2020, 54(10): 1060-1068. [12] MURAYAMA H, SAKUMA M, TAKAHASHI Y, et al.Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: the Japan adverse drug events study[J]. Pharmacology Research & Perspectives, 2018, 6(1): e00373. [13] MURALI M, SUPPES SL, FELDMAN K, et al.Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children’s hospital[J]. PloS one, 2021, 16(1): e0245368. [14] NAMAZI MR.Statins: novel additions to the dermatologic arsenal?[J]. Exp Dermatol,2004, 13(6): 337-339. [15] LV M, JIANG S, FU J, et al.Toxic epidermal necrolysis in a patient on atorvastatin therapy expressing human leukocyte antigen alleles: a case report[J]. Medicine (Baltimore), 2021, 100(3): e24392. [16] COZZANI E, SCAPARRO M, PARODI A.A case of psoriasis worsened by atorvastatin[J]. J Dermatol Case Rep, 2009, 3(4): 60-61. [17] HUERTAS AJ, RAMIREZ-HERNANDEZ M, MERIDA-FERNANDEZ C, et al.Fixed drug eruption due to atorvastatin[J]. J Investig Allergol Clin Immunol, 2015, 25(2):155-156 [18] ZHU YM, CAO JG, ZHOU YS.Application of gene detection in individualized treatment of lipid -lowering drugs[J]. China Pharmacy(中国药房), 2023, 34(9): 1147-1152. |